Entrapment of phenytoin into microspheres of oleaginous materials: Process development and in vitro evaluation of drug release

Drug Development and Industrial Pharmacy

Volumn 23, Issue 12, 1997, Pages 1145-1152

  Giannola, L I ^a   De Caro, V ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DECANOIC ACID; FATTY ACID; GLYCEROL STEARATE; LAURIC ACID; LIPOSPHERE; MICROSPHERE; MYRISTIC ACID; PALMITIC ACID; PHENYTOIN; STEARIC ACID; UNCLASSIFIED DRUG;

ARTICLE; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; ENCAPSULATION; PARTICLE SIZE;

EID: 0031442756     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709146151     Document Type: Article

References (25)

1. The Merck Manual of Diagnosis and Therapy, 16th ed., Merck Research Laboratories, Rahway, NJ, 1992, p. 1441.
2. J. E. F. Reynolds, Martindale The Extra Pharmacopoeia, 30th ed., The Pharmaceutical Press, London, 1993, p. 304.
3. D. Fleisher, C. L. Lippert, N. Sheth, C. Reppas, and J. Wlodyga, J. Controlled Release, 11, 41 (1990).
4. M. C. Meyer, and A. B. Straughn, Am. J. Hosp. Pharm., 50, S17 (1993).
5. A. T. Cacek, Ther. Drug Monit., 8, 166 (1986).
6. D. L. McCauley, T. N. Tozer, and M. E. Winter, Ther. Drug Monit., 11, 540 (1989).
7. C. F. Lam, Q. Jiang, and R. E. Notari, Compul. Biol. Med., 23, 475 (1993).
8. J. R. Irvin, and R. E. Notari, Pharm. Res., 8, 232 (1991).
9. H. Ohmori, T. Kobayashi, and M. Yasuda, Neurotoxicol. Teratol., 14, 159 (1992).
10. S. Bahn, U. Ganter, J. Bauer, U. Otten, and B. Volk, Brain Res., 615, 160 (1993).
11. S. N. Wickramasinghe, et al, Br. Med. J., 4, 136 (1975).
12. C. E. Andrade Mena, J. A. J. Sardo Olmedo, and E. J. Ramirez Lizardo, J. Neuroimmunol., 50, 3 (1994).
13. Physicians' Desk Reference, 49th ed., Medical Economics Co., Oradell, NJ (1994).
14. D. Vanoverloop, R. R. Schnell, E. A. Harvey, and L. B. Holmes, Neurotoxycol. Teratol., 14, 329 (1992).
15. J. E. F. Reynolds, Martindale The Extra Pharmacopoeia, 30th ed., The Pharmaceutical Press, London (1993), p. 308.
16. E. O. Savio, P. Fagiolino, M. Jelen, and A. S. Leon, Boll. Chim. Farm., 133, 239 (1994).
17. L. I. Giannola, V. Di Stefano, and V. De Caro, Pharmazie. 48, 123 (1993).
18. L. I. Giannola, V. De Caro, and V. Di Stefano, Drug Dev. Ind. Pharm., 20, 2285 (1994).
19. L. I. Giannola, V. De Caro, V. Di Stefano, and M. C. Rizzo, Pharmazie. 48, 917 (1993).
20. H. Bechgaard, and G. H. Nielsen, Drug Dev. Ind. Pharm., 4, 53 (1978).
21. I. Karakasa, N. Yiagi, M. Shibata, H. Keumotsu, H. Sekikawa, M. Takada, Biol. Pharm. Bull., 17, 432 (1994).
22. G. Raymond, M. Degennaro, and R. Mikeal, Drug Dev. Ind. Pharm., 16, 1025 (1990).
23. L. I. Giannola, V. De Caro, and M. C. Rizzo, Drug Dev. Ind. Pharm., 21, 793 (1995).
24. L. I. Giannola, V. De Caro, and A. Severino, Drug Dev. Ind. Pharm., 21, 1563 (1995).
25. S. S. Davis, J. G. Hardy, M. J. Taylor, D. R. Whalley, and C. G. Wilson, Int. J. Pharmaceut., 21, 167 (1984).